000 01563 a2200445 4500
005 20250511194149.0
264 0 _c19920724
008 199207s 0 0 eng d
022 _a0952-0600
024 7 _a10.1016/0952-0600(92)90029-g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLammers, J W
245 0 0 _aBronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast--MK-0679) in asthmatic patients.
_h[electronic resource]
260 _bPulmonary pharmacology
_cJun 1992
300 _a121-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdult
650 0 4 _aAlbuterol
_xpharmacology
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aBronchodilator Agents
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPropionates
_xadministration & dosage
650 0 4 _aQuinolines
_xadministration & dosage
650 0 4 _aRespiratory Function Tests
650 0 4 _aSRS-A
_xantagonists & inhibitors
700 1 _aVan Daele, P
700 1 _aVan den Elshout, F M
700 1 _aDecramer, M
700 1 _aBuntinx, A
700 1 _aDe Lepeleire, I
700 1 _aFriedman, B
773 0 _tPulmonary pharmacology
_gvol. 5
_gno. 2
_gp. 121-5
856 4 0 _uhttps://doi.org/10.1016/0952-0600(92)90029-g
_zAvailable from publisher's website
999 _c1617708
_d1617708